As depicted in Figs. 1C–1E, the mutation frequency of PLA2G16 in pancreatic cancer appears relatively low, at 0.3%, with amplification identified as the most prevalent genetic alteration, followed by deep deletion. This evidence concerns the gene PLAAT3 and familial pancreatic carcinoma.